| Company Name: | Dade Behring Holdings, Inc. | | Ticker Symbol: | DADE | | | WWW Address: | www.dadebehring.com | | CEO: | James W. P. Reid-Anderson | | No. of Employees: | 6,400 | | Common Issue Type: | CS | | Business Description: | The Company develops, manufactures and markets clinical diagnostic instruments, reagents, consumable supplies and services worldwide.
|
| | | Industry Information: | DRUGS - Diagnostic Support [more like this] |
|
| Price | Day Change | Bid | Ask | Open | High | Low | Volume | | |  | - | - | 0 | 76.99 | 76.95 | - |
| Market Cap (mil) | Shares Outstanding (mil) | Beta | EPS | DPS | P/E | Yield | 52-Wks-Range |
| 6,167.6 | 80.1 | 0.42 | 1.36 | 0.20 | 43.7 | 0.3 | 77.00 - 35.77 |
|
| KEY FIGURES (Latest Twelve Months - LTM) | | Yesterday's Close | 76.98 | $ | | PE Ratio - LTM | 43.7 | |
| Market Capitalisation | 6,167.6 | mil |
| Latest Shares Outstanding | 80.1 | mil |
| Earnings pS (EPS) | 1.36 | $ |
| Dividend pS (DPS) | 0.20 | ¢ |
| Dividend Yield | 0.3 | % |
| Dividend Payout Ratio | 15 | % |
| Revenue per Employee | 271,750 | $ |
| Effective Tax Rate | 32.7 | % |
| Float | 79.2 | mil |
| Float as % of Shares Outstanding | 98.8 | % |
| Foreign Sales | 842 | mil |
| Domestic Sales | 897 | mil |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 30.70 | % |
| Research & Devlopment (R&D) as % of Revenue | 8.50 | % |
| Gross Profit Margin | 65.0 | % |
| EBITDA Margin | 23.0 | % |
| Pre-Tax Profit Margin | 10.6 | % |
| Assets Turnover | 1.0 | % |
| Return on Assets (ROA) | 7.6 | % |
| Return on Equity (ROE) | 19.3 | % |
| Return on Capital Invested (ROCI) | 10.8 | % |
| Current Ratio | 2.1 | |
| Leverage Ratio (Assets/Equity) | 2.5 | |
| Interest Cover | 6.9 | |
| Total Debt/Equity (Gearing Ratio) | 0.78 | |
| LT Debt/Total Capital | 44.0 | % |
| Working Capital pS | 5.19 | $ |
| Cash pS | 0.64 | $ |
| Book-Value pS | 9.55 | $ |
| Tangible Book-Value pS | 3.39 | $ |
| Cash Flow pS | 3.93 | $ |
| Free Cash Flow pS | 2.19 | $ |
 |
| KEY FIGURES (LTM): Price info |
| Price/Book Ratio | 8.06 | |
| Price/Tangible Book Ratio | 22.71 | |
| Price/Cash Flow | 19.6 | |
| Price/Free Cash Flow | 35.2 | |
| P/E as % of Industry Group | 79.0 | % |
| P/E as % of Sector Segment | 0.0 | % |
| | | Balance Sheet (at a glance) in Millions |
| | | | | | DIVIDEND INFO | | Type of Payment | Cash Payment |
| Dividend Rate | 0.20 |
| Current Dividend Yield | 0.3 |
| 5-Y Average Dividend Yield | 0.0 |
| Payout Ratio | 15.0 |
| 5-Y Average Payout Ratio | 0.0 |
| |
| |
| |
| |
| |
|  | | Share price performance previous 3 years |
|
 | | | Share price performance intraday |
|
 | |
| |
| PRICE/VOLUME | High | Low | Close | % Price Chg | % Price Chg vs. Mkt. | Avg. Daily Vol | Total Vol |
| 1 Week | - | - | - | 0.1 | 102 | 6,153 | 8,259 |
| 4 Weeks | 77.00 | 76.58 | 76.63 | 0.5 | 106 | 4,332 | 77,973 |
| 13 Weeks | 77.00 | 73.72 | 74.70 | 3.1 | 102 | 5,383 | 333,761 |
| 26 Weeks | 77.00 | 50.34 | 50.42 | 52.7 | 156 | 8,411 | 1,051,397 |
| 52 Weeks | 77.00 | 35.77 | 36.10 | 113.2 | 200 | 6,847 | 1,698,106 |
| YTD | 77.00 | 38.94 | - | 93.4 | 186 | 6,946 | 1,493,317 |
| Moving Average | 5-Days | 10-Days | 10-Weeks | 30-Weeks | 200-Days | Beta (60-Mnth) | Beta (36-Mnth) |
| 76.93 | 76.93 | 76.29 | 63.51 | 58.43 | 0.42 | 0.13 |
|
| |
| GROWTH RATES | 5-Year
Growh | R² of 5-Year Growth | 3-Year
Growth |
| Revenue | 0.00 | 0.0 | 5.63 |
| Income | 0.00 | 0.0 | 23.25 |
| Dividend | 0.00 | 0.0 | 0.00 |
| Capital Spending | 0.00 | NA | 15.63 |
| R&D | 0.00 | NA | 8.46 |
| Normalized Inc. | 0.00 | NA | 34.30 |
| | | CHANGES | YTD vs.
Last YTD | Curr Qtr vs.
Qtr 1-Yr ago | Annual vs.
Last Annual |
| Revenue % | 10.2 | 12.1 | 4.9 |
| Earnings % | 27.1 | 30.1 | -3.9 |
| EPS % | 34.2 | 36.4 | 0.0 |
| EPS $ | 0.39 | 0.12 | 0.00 |
|
| |
| SOLVENCY RATIOS | | SHORT-TERM SOLVENCY RATIOS (LIQUIDITY) |
| Net Working Capital Ratio | 18.42 |
| Current Ratio | 1.9 |
| Quick Ratio (Acid Test) | 1.0 |
| Liquidity Ratio (Cash) | 0.07 |
| Receivables Turnover | 5.2 |
| Average Collection Period | 69 |
| Working Capital/Equity | 42.7 |
| Working Capital pS | 4.17 |
| Cash-Flow pS | 3.38 |
| Free Cash-Flow pS | 1.52 |
| FINANCIAL STRUCTURE RATIOS |
| Altman's Z-Score Ratio | 5.06 |
| Financial Leverage Ratio (Assets/Equity) | 2.3 |
| Debt Ratio | 56.9 |
| Total Debt/Equity (Gearing Ratio) | 0.63 |
| LT Debt/Equity | 0.61 |
| LT Debt/Capital Invested | 53.6 |
| LT Debt/Total Liabilities | 46.4 |
| Interest Cover | 7.6 |
| Interest/Capital Invested | 1.78 |
| | | | VALUATION RATIOS | | MULTIPLES |
| PQ Ratio | 111.73 |
| Tobin's Q Ratio | 3.29 |
| Current P/E Ratio - LTM | 43.70 |
| Enterprise Value (EV)/EBITDA | 18.71 |
| Enterprise Value (EV)/Free Cash Flow | 62.41 |
| Dividend Yield | 0.3 |
| Price/Tangible Book Ratio - LTM | 22.71 |
| Price/Book Ratio - LTM | 8.06 |
| Price/Cash Flow Ratio | 19.6 |
| Price/Free Cash Flow Ratio - LTM | 35.2 |
| Price/Sales Ratio | 3.30 |
| P/E Ratio (1 month ago) - LTM | 43.5 |
| P/E Ratio (26 weeks ago) - LTM | 34.5 |
| P/E Ratio (52 weeks ago) - LTM | 23.9 |
| 5-Y High P/E Ratio | 0.0 |
| 5-Y Low P/E Ratio | 0.0 |
| 5-Y Average P/E Ratio | 0.0 |
| Current P/E Ratio as % of 5-Y Average P/E | 0 |
| P/E as % of Industry Group | 79.0 |
| P/E as % of Sector Segment | 0.0 |
| Current 12 Month Normalized P/E Ratio - LTM | 38.5 |
| PER SHARE FIGURES |
| LT Debt pS | 5.97 |
| Current Liabilities pS | 4.43 |
| Tangible Book Value pS - LTM | 3.39 |
| Book Value pS - LTM | 9.55 |
| Capital Invested pS | 16.28 |
| Cash pS - LTM | 0.64 |
| Cash Flow pS - LTM | 3.93 |
| Free Cash Flow pS - LTM | 2.19 |
| Earnings pS (EPS) | 1.36 |
| | | | OPERATING RATIOS | | PROFITABILITY RATIOS |
| Free Cash Flow Margin | 7.26 |
| Free Cash Flow Margin 5YEAR AVG | 8.39 |
| Net Profit Margin | 6.9 |
| Net Profit Margin - 5YEAR AVRG. | 4.8 |
| Equity Productivity | 2.15 |
| Return on Equity (ROE) | 14.8 |
| Return on Equity (ROE) - 5YEAR AVRG. | 8.4 |
| Capital Invested Productivity | 1.33 |
| Return on Capital Invested (ROCI) | 9.2 |
| Return on Capital Invested (ROCI) - 5YEAR AVRG. | 4.9 |
| Assets Productivity | 0.90 |
| Return on Assets (ROA) | 6.4 |
| Return on Assets (ROA) - 5YEAR AVRG. | 3.4 |
| Gross Profit Margin | 65.0 |
| Gross Profit Margin - 5YEAR AVRG. | 62.9 |
| EBITDA Margin - LTM | 23.0 |
| EBIT Margin - LTM | 12.4 |
| Pre-Tax Profit Margin | 10.2 |
| Pre-Tax Profit Margin - 5YEAR AVRG. | 7.2 |
| Effective Tax Rate | 32.7 |
| Effective Tax Rate - 5YEAR AVRG. | 25.7 |
| EFFICIENCY RATIOS |
| Cash Conversion Cycle | 176 |
| Revenue per Employee | 271,750 |
| Net Income per Employee | 18,750 |
| Average Collection Period | 74 |
| Receivables Turnover | 5.2 |
| Day's Inventory Turnover Ratio | 102 |
| Inventory Turnover | 3.5 |
| Inventory/Sales | 10.9 |
| Accounts Payble/Sales | 4.54 |
| Assets/Revenue | 1.11 |
| Net Working Capital Turnover | 5.04 |
| Fixed Assets Turnover | 1.50 |
| Total Assets Turnover | 0.9 |
| Revenue per $ Cash | 71.28 |
| Revenue per $ Plant | 3.56 |
| Revenue per $ Common Equity | 2.15 |
| Revenue per $ Capital Invested | 1.33 |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 32.5 |
| SG&A Expense as % of Revenue - 5YEAR AVRG. | 33.6 |
| Research & Devlopment (R&D) as % of Revenue | 9.2 |
| R&D Expense as % of Revenue - 5YEAR AVRG. | 9.2 |
|
|  
|
| |
 |  |